Concourse Financial Group Securities’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-4,240
| Closed | -$52.1K | – | 5269 |
|
2024
Q4 | $52.1K | Sell |
4,240
-321
| -7% | -$3.94K | ﹤0.01% | 1194 |
|
2024
Q3 | $125K | Buy |
4,561
+117
| +3% | +$3.21K | 0.01% | 880 |
|
2024
Q2 | $109K | Buy |
4,444
+30
| +0.7% | +$734 | 0.01% | 909 |
|
2024
Q1 | $94.1K | Sell |
4,414
-64
| -1% | -$1.36K | 0.01% | 938 |
|
2023
Q4 | $85.7K | Sell |
4,478
-806
| -15% | -$15.4K | 0.01% | 944 |
|
2023
Q3 | $84.8K | Sell |
5,284
-110
| -2% | -$1.76K | 0.01% | 905 |
|
2023
Q2 | $125K | Buy |
5,394
+370
| +7% | +$8.58K | 0.01% | 795 |
|
2023
Q1 | $117K | Sell |
5,024
-410
| -8% | -$9.52K | 0.01% | 822 |
|
2022
Q4 | $78.8K | Sell |
5,434
-103
| -2% | -$1.5K | 0.01% | 911 |
|
2022
Q3 | $106K | Sell |
5,537
-204
| -4% | -$3.91K | 0.01% | 706 |
|
2022
Q2 | $104K | Buy |
5,741
+572
| +11% | +$10.4K | 0.01% | 796 |
|
2022
Q1 | $130K | Sell |
5,169
-43
| -0.8% | -$1.08K | 0.01% | 769 |
|
2021
Q4 | $144K | Buy |
5,212
+195
| +4% | +$5.39K | 0.01% | 845 |
|
2021
Q3 | $162K | Sell |
5,017
-235
| -4% | -$7.59K | 0.01% | 793 |
|
2021
Q2 | $161K | Sell |
5,252
-1,346
| -20% | -$41.3K | 0.01% | 783 |
|
2021
Q1 | $201K | Sell |
6,598
-524
| -7% | -$16K | 0.01% | 686 |
|
2020
Q4 | $141K | Buy |
7,122
+2,346
| +49% | +$46.4K | 0.01% | 753 |
|
2020
Q3 | $62K | Buy |
4,776
+287
| +6% | +$3.73K | 0.01% | 973 |
|
2020
Q2 | $51K | Buy |
4,489
+1,510
| +51% | +$17.2K | 0.01% | 982 |
|
2020
Q1 | $43K | Buy |
+2,979
| New | +$43K | ﹤0.01% | 963 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 4377 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 4167 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 4364 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 4304 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 4182 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 3895 |
|